2013 annual financial data
Halozyme Therapeutics 2013 Net margin
Direct answer
Net margin was -152.33%.
Operating income was -80,433,637 USD and net income was -83,478,551 USD.
Operating cash flow was -49,339,479 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 54,799,447 USD
- Operating income
- -80,433,637 USD
- Net income
- -83,478,551 USD
- Operating cash flow
- -49,339,479 USD
Explore related company data
View all 2013 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Halozyme Therapeutics financial years